Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy

Fertility and Sterility

Volumn 105, Issue 2, 2016, Pages 410-416

  Bonne, Stéphanie ^a   Sauleau, Eric ^b   Sananes, Nicolas ^a   Akaladios, Cherif ^c   Rongières, Catherine ^a   Pirrello, Olivier ^a  

^a SIHCUS CMCO Centre Medico Chirurgical et Obstetrical   (France)

^b HÔPITAL CIVIL   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

ART; early fetal growth; hCG; PAPP A; Robinson's curve

Indexed keywords

BIOCHEMICAL MARKER; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; PAPPA1 PROTEIN, HUMAN;

AMENORRHEA; ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; ECHOGRAPHY; EMBRYO TRANSFER; FEMALE; FIRST TRIMESTER PREGNANCY; FROZEN EMBRYO TRANSFER; GESTATIONAL AGE; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LAST MENSTRUAL PERIOD; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRISOMY 21; ADULT; BLOOD; COMPARATIVE STUDY; DOWN SYNDROME; FERTILITY; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; GENETICS; INFERTILITY; PATHOPHYSIOLOGY; PREGNANCY; TREATMENT OUTCOME;

ADULT; BIOMARKERS; CHORIONIC GONADOTROPIN; CROWN-RUMP LENGTH; DOWN SYNDROME; FEMALE; FERTILITY; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMANS; INFERTILITY; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 84975761170     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.10.031     Document Type: Article

References (35)

1. 1 French Agence de la Biomédecine. French Agence de la Biomédecine. Available at: http://www.agence-biomedecine.fr. Last accessed December 3, 2015.
2. 2 Gjerris, A.C., Loft, A., Pinborg, A., Tabor, A., Christiansen, M., First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length. Ultrasound Obstet Gynecol 32 (2008), 612–617.
3. 3 Tunon, K., Eik-Nes, S.H., Grottum, P., von Düring, V., Kahn, J.A., Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown rump length and biparietal diameter. Ultrasound Obstet Gynecol 15 (2000), 41–46.
4. 4 Sladkevicius, P., Saltvedt, S., Almstrom, H., Kublickas, M., Grunewald, C., Valentin, L., Ultrasound dating at 12-14 weeks of gestation. A prospective cross-validation of established dating formulae in in vitro fertilized pregnancies. Ultrasound Obstet Gynecol 26 (2005), 504–511.
5. 5 Nicolaides, K.H., Azar, G., Byrne, D., Mansur, C., Marks, K., Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304 (1992), 867–869.
6. 6 Wald, N.J., George, L., Smith, D., Densem, J.W., Petterson, K., Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynecol 104 (1996), 407–412.
7. 7 Anckaert, E., Schiettecatte, J., Sleurs, E., Devroey, P., Smitz, J., First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril 90 (2008), 1206–1210.
8. 8 Amor, D.J., Xu, J., Halliday, J.L., Francis, I., Healy, D.L., Baker, H.W., et al. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 24 (2009), 1330–1338.
9. 9 Bender, F., Hecken, J., Reinsberg, J., Berg, C., van der Ven, H., Gembruch, U., et al. Altered first-trimester screening markers after IVF/ICSI: no relationship with small-for-gestational-age and number of embryos transferred. Reprod Biomed Online 20 (2010), 516–522.
10. 10 Bellver, J., Casanova, C., Garrido, N., Lara, C., Remohi, J., Pellicer, A., et al. Addictive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening. Fertil Steril 100 (2013), 1314–1320.
11. 11 Bellver, J., Lara, C., Soares, S.R., Ramirez, A., Pellicer, A., Remohi, J., et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 20 (2005), 2623–2627.
12. 12 Bersinger, N.A., Wunder, D., Vanderlick, F., Chanson, A., Pescia, G., Janecdk, P., et al. Maternal serum levels of placental proteins after in vitro fertilization and their implications for prenatal screening. Prenat Diagn 24 (2004), 471–477.
13. 13 Ghisoni, L., Ferazzi, E., Castagna, C., Levi Setti, P.E., Masini, A.C., Pigi, A., Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 24:Suppl B (2003), S99–S103.
14. 14 Giorgetti, C., Vanden Meerschaut, F., de Roo, C., Saunier, O., Quarello, E., Hairion, D., et al. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies. Hum Reprod 28 (2013), 2636–2642.
15. 15 Gjerris, A.C., Loft, A., Pinborg, A., Christiansen, M., Tabor, A., First trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 33 (2009), 8–17.
16. 16 Engels, M.A., Kooij, M., Schats, R., Twisk, J.W., Blankenstein, M.A., van Vugt, J.M., First trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 30 (2010), 372–377.
17. 17 Hui, P.W., Lam, Y.H., Tang, M.H., Ng, E.H., Yeung, W.S., Ho, P.C., Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 25 (2005), 390–393.
18. 18 Hui, P.W., Tang, M.H., Lam, Y.H., Yeung, W.S., Ng, E.H., Ho, P.C., Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 25 (2005), 234–238.
19. 19 Lambert-Messerlian, G., Dugloff, L., Vidaver, J., Canick, J.A., Malone, F.D., Ball, R.H., et al. First-trimester and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 26 (2006), 672–678.
20. 20 Liao, A.W., Heath, V., Kametas, N., Spencer, K., Nicolaides, K.H., First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16 (2001), 1501–1504.
21. 21 Maymon, R., Shulman, A., Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod 17 (2002), 1081–1085.
22. 22 Maymon, R., Shulman, A., Integrated first- and second-trimester Down's syndrome screening tests among unaffected IVF pregnancies. Prenat Diagn 24 (2004), 125–129.
23. 23 Niemimaa, M., Heinonen, S., Seppala, M., Hippelainen, M., Martikainen, H., Ryynanen, M., First trimester screening for Down's syndrome in in vitro fertilization pregnancies. Fertil Steril 76 (2001), 1282–1283.
24. 24 Orlandi, F., Rossi, C., Allegra, A., Krantz, D., Hallahan, T., Orlandi, E., et al. First trimester screening with free B-HCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22 (2002), 718–721.
25. 25 Tul, N., Novak-Antolic, Z., Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 26 (2006), 1206–1211.
26. 26 Wodjemann, K.R., Larsen, S.O., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A., First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21 (2001), 563–565.
27. 27 Kagan, K.O., Wright, D., Spencer, K., Molina, F.S., Nikolaides, K.H., First trimester screening for trisomy 21 by free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31 (2008), 493–502.
28. 28 Matilainen, M., Peuhkurinen, S., Laitinen, P., Jarvela, I., Morin-Papunen, L., Ryynanen, M., In combined first-trimester Down syndrome screening, the false positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies. Fertil Steril 95 (2011), 378–381.
29. 29 Robinson, H.P., Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy. Br Med J 4 (1973), 28–31.
30. 30 Kleijkers, S., van Montfoort, A., Smits, L., Viechtbauer, W., Roseboom, T., Nelissen, E., et al. IVF culture medium affects post-natal weight in humans during the first 2 years of life. Hum Reprod 29 (2014), 661–669.
31. 31 Vergouw, C., Kostelijk, E., Doejaaren, E., Hompes, P.G., Lambalk, C.B., Schats, R., The influence of the type of embryo culture medium on neonatal birthweight after single embryo transfer in IVF. Hum Reprod 27 (2012), 2619–2626.
32. 32 Carrasco, B., Boada, M., Rodriguez, I., Coroleu, B., Barri, P., Does culture medium influence offspring birth weight?. Fertil Steril 100 (2013), 283–288.
33. 33 Lin, S., Li, M., Lian, Y., Chen, L., Liu, P., No effect of embryo culture media on birthweight and length of newborns. Hum Reprod 28 (2013), 1762–1767.
34. 34 Spencer, K., Cowans, N.J., Nicolaides, K.H., Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 28 (2008), 7–10.
35. 35 Opdahl, S., Henningsen, A.A., Tiitinen, A., Bergh, S., Pinborg, A., Romundstad, P.R., et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the coNARTaS group. Hum Reprod 30 (2015), 1724–1731.